HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Dario Neri Selected Research

Antineoplastic Agents (Antineoplastics)

1/2017Linker stability influences the anti-tumor activity of acetazolamide-drug conjugates for the therapy of renal cell carcinoma.
11/2015Antibody Format and Drug Release Rate Determine the Therapeutic Activity of Noninternalizing Antibody-Drug Conjugates.
4/2014A small-molecule drug conjugate for the treatment of carbonic anhydrase IX expressing tumors.
1/2014Abundant in vitro expression of the oncofetal ED-B-containing fibronectin translates into selective pharmacodelivery of (131)I-L19SIP in a prostate cancer patient.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Dario Neri Research Topics

Disease

214Neoplasms (Cancer)
05/2024 - 03/2002
18Renal Cell Carcinoma (Grawitz Tumor)
07/2023 - 04/2010
18Melanoma (Melanoma, Malignant)
11/2020 - 04/2011
17Neoplasm Metastasis (Metastasis)
01/2021 - 05/2007
16Inflammation (Inflammations)
01/2023 - 04/2007
13Teratocarcinoma
09/2018 - 07/2002
12Necrosis
01/2023 - 01/2007
11Arthritis (Polyarthritis)
01/2021 - 01/2007
9Colorectal Neoplasms (Colorectal Cancer)
04/2024 - 12/2008
9Carcinoma (Carcinomatosis)
12/2020 - 04/2006
9Lymphoma (Lymphomas)
01/2018 - 03/2009
8Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
09/2023 - 09/2013
7Leukemia
01/2021 - 09/2013
6Rheumatoid Arthritis
01/2019 - 03/2002
6Hematologic Neoplasms (Hematological Malignancy)
11/2017 - 06/2008
6Kidney Neoplasms (Kidney Cancer)
01/2017 - 11/2006
5Prostatic Neoplasms (Prostate Cancer)
05/2024 - 01/2014
5Hypoxia (Hypoxemia)
07/2023 - 06/2004
5Glioma (Gliomas)
01/2023 - 07/2006
5Colitis
12/2022 - 08/2015
5Sarcoma (Soft Tissue Sarcoma)
01/2021 - 01/2017
4Fibrosis (Cirrhosis)
12/2016 - 02/2010
4Experimental Arthritis
01/2016 - 01/2007
4Breast Neoplasms (Breast Cancer)
01/2015 - 04/2007
4Atherosclerotic Plaque (Atheroma)
02/2011 - 12/2004
3Colonic Neoplasms (Colon Cancer)
04/2024 - 12/2008
3Pulmonary Hypertension
01/2024 - 03/2021
3Brain Neoplasms (Brain Tumor)
01/2023 - 04/2007
3Psoriasis (Pustulosis Palmaris et Plantaris)
12/2022 - 11/2014
3Fibrosarcoma
01/2017 - 04/2006

Drug/Important Bio-Agent (IBA)

112Proteins (Proteins, Gene)FDA Link
05/2024 - 03/2002
82Fibronectins (Fibronectin)IBA
01/2023 - 03/2002
72CytokinesIBA
03/2024 - 03/2002
63AntigensIBA
05/2024 - 07/2003
49AntibodiesIBA
04/2023 - 03/2002
37Interleukin-2 (IL2)IBA
04/2024 - 03/2002
36Monoclonal AntibodiesIBA
05/2024 - 12/2002
27LigandsIBA
05/2024 - 12/2002
27Immunoglobulin FragmentsIBA
04/2023 - 07/2002
26F8 monoclonal antibodyIBA
01/2021 - 06/2008
22TenascinIBA
01/2020 - 06/2005
19Immunoconjugates (Immunoconjugate)IBA
02/2024 - 11/2002
19Protein Isoforms (Isoforms)IBA
01/2020 - 03/2002
16Carbonic Anhydrase IXIBA
07/2023 - 08/2009
16Peptides (Polypeptides)IBA
01/2023 - 07/2002
14Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
04/2023 - 06/2003
13Interleukin-12 (IL 12)IBA
03/2024 - 06/2003
12Immunoglobulin G (IgG)IBA
01/2023 - 11/2002
8Acetazolamide (Diamox)FDA LinkGeneric
10/2020 - 08/2009
8Interleukin-4 (Interleukin 4)IBA
01/2018 - 01/2014
8Coloring Agents (Dyes)IBA
04/2014 - 06/2005
7CollagenIBA
01/2023 - 01/2007
7Cytotoxins (Cytolysins)IBA
12/2022 - 04/2006
7Biomarkers (Surrogate Marker)IBA
01/2022 - 04/2007
7Immune Checkpoint InhibitorsIBA
01/2022 - 01/2019
6DNA (Deoxyribonucleic Acid)IBA
05/2024 - 04/2011
6Radioisotopes (Radionuclides)IBA
01/2022 - 01/2010
6Doxorubicin (Adriamycin)FDA LinkGeneric
01/2021 - 10/2008
6Indicators and Reagents (Reagents)IBA
11/2020 - 08/2005
6Dacarbazine (DIC)FDA LinkGeneric
01/2020 - 12/2011
6Interleukin-10 (Interleukin 10)IBA
01/2019 - 01/2007
6Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
12/2018 - 11/2002
5Bispecific AntibodiesIBA
04/2024 - 11/2012
5Vascular Endothelial Growth Factor CIBA
01/2023 - 08/2010
5monomethyl auristatin EIBA
01/2021 - 01/2017
5Dexamethasone (Maxidex)FDA LinkGeneric
01/2019 - 08/2014
4Interleukin-9 (Interleukin 9)IBA
01/2024 - 01/2021
4Fluorescein (Funduscein)FDA LinkGeneric
11/2021 - 02/2013
4Interleukin-15 (Interleukin 15)IBA
01/2021 - 05/2007
4Messenger RNA (mRNA)IBA
10/2020 - 06/2004
4Melphalan (Alkeran)FDA LinkGeneric
01/2020 - 05/2004
4Glycoproteins (Glycoprotein)IBA
01/2020 - 05/2006
4sodium sulfate (sodium bisulfate)FDA LinkGeneric
10/2019 - 08/2015
4Dextrans (Dextran)FDA Link
10/2019 - 08/2015
4Sunitinib (Sutent)FDA Link
06/2018 - 12/2010
4DisulfidesIBA
01/2017 - 04/2014
4DipeptidesIBA
01/2017 - 12/2016
4Antineoplastic Agents (Antineoplastics)IBA
01/2017 - 01/2014
4Paclitaxel (Taxol)FDA LinkGeneric
09/2014 - 04/2012
4oncofetal fibronectinIBA
02/2012 - 04/2007
4Biotin (Vitamin H)FDA Link
04/2011 - 04/2007
3Small Molecule LibrariesIBA
05/2024 - 06/2021
3Carcinoembryonic AntigenIBA
04/2024 - 08/2020
3ProdrugsIBA
12/2022 - 05/2004
3Extracellular Matrix ProteinsIBA
01/2022 - 05/2003
3Chimeric Antigen ReceptorsIBA
11/2021 - 01/2020
3Therapeutic UsesIBA
01/2021 - 06/2003
3EnzymesIBA
01/2021 - 01/2017
3EpitopesIBA
10/2020 - 03/2009
3AcidsIBA
02/2019 - 01/2016
3Sorafenib (BAY 43-9006)FDA Link
01/2017 - 12/2010
3Maytansine (Maitansine)IBA
11/2015 - 04/2014

Therapy/Procedure

97Therapeutics
04/2024 - 03/2002
16Immunotherapy
09/2023 - 09/2014
12Drug Therapy (Chemotherapy)
01/2021 - 04/2006
11Intravenous Injections
12/2022 - 07/2002
9Intravenous Administration
01/2021 - 01/2014
7Radioimmunotherapy
05/2014 - 07/2006
3Castration
05/2024 - 01/2023
3Hematopoietic Stem Cell Transplantation
09/2023 - 05/2015